US Patent 8093356 Pegylated human interferon polypeptides
Patent 8093356 was granted and assigned to Ambrx on January, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8093356 Pegylated human interferon polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
